PT699075E - Factor vii modificado para inibicao de restenose vascular e de deposicao de plaquetas - Google Patents
Factor vii modificado para inibicao de restenose vascular e de deposicao de plaquetasInfo
- Publication number
- PT699075E PT699075E PT94918092T PT94918092T PT699075E PT 699075 E PT699075 E PT 699075E PT 94918092 T PT94918092 T PT 94918092T PT 94918092 T PT94918092 T PT 94918092T PT 699075 E PT699075 E PT 699075E
- Authority
- PT
- Portugal
- Prior art keywords
- factor vii
- restenose
- vascular
- inhibition
- modified factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6437—Coagulation factor VIIa (3.4.21.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21021—Coagulation factor VIIa (3.4.21.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6572593A | 1993-05-21 | 1993-05-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT699075E true PT699075E (pt) | 2002-05-31 |
Family
ID=22064676
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT94918092T PT699075E (pt) | 1993-05-21 | 1994-05-23 | Factor vii modificado para inibicao de restenose vascular e de deposicao de plaquetas |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0699075B1 (pt) |
JP (1) | JPH08510746A (pt) |
AT (1) | ATE210458T1 (pt) |
AU (1) | AU703110B2 (pt) |
CA (1) | CA2162726A1 (pt) |
DE (1) | DE69429429T2 (pt) |
DK (1) | DK0699075T3 (pt) |
ES (1) | ES2169074T3 (pt) |
HU (1) | HU219682B (pt) |
PT (1) | PT699075E (pt) |
WO (1) | WO1994027631A1 (pt) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5788965A (en) * | 1991-02-28 | 1998-08-04 | Novo Nordisk A/S | Modified factor VII |
US5997864A (en) | 1995-06-07 | 1999-12-07 | Novo Nordisk A/S | Modified factor VII |
US5833982A (en) | 1991-02-28 | 1998-11-10 | Zymogenetics, Inc. | Modified factor VII |
US5817788A (en) * | 1991-02-28 | 1998-10-06 | Zymogenetics, Inc. | Modified factor VII |
US5736364A (en) * | 1995-12-04 | 1998-04-07 | Genentech, Inc. | Factor viia inhibitors |
US7247708B2 (en) | 1997-10-23 | 2007-07-24 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6747003B1 (en) | 1997-10-23 | 2004-06-08 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
DE60138364D1 (de) | 2000-02-11 | 2009-05-28 | Bayer Healthcare Llc | Gerinnungsfaktor vii oder viia konjugate |
EP2267026A1 (en) | 2000-04-12 | 2010-12-29 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7220837B1 (en) | 2000-04-28 | 2007-05-22 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US7812132B2 (en) | 2000-04-28 | 2010-10-12 | Regents Of The University Of Minnesota | Modified vitamin K-dependent polypeptides |
US6905683B2 (en) | 2000-05-03 | 2005-06-14 | Novo Nordisk Healthcare A/G | Human coagulation factor VII variants |
US20030211094A1 (en) | 2001-06-26 | 2003-11-13 | Nelsestuen Gary L. | High molecular weight derivatives of vitamin k-dependent polypeptides |
IL154520A0 (en) * | 2000-09-13 | 2003-09-17 | Novo Nordisk As | Human coagulation factor vii variants |
BR0113854A (pt) | 2000-09-13 | 2004-07-06 | Novo Nordisk As | Polipeptìdeo do fator vii, construção de ácido nucleìco, célula hospedeira recombinante animal transgênico, planta transgênica, método para produzir o polipeptìdeo do fator vii, composição farmacêutica, uso de um polipeptìdeo do fator vii, e, métodos para o tratamento de episódios de sangramento e para tratamento ou profilaxia de distúrbios de sangramento em um indivìduo ou para a intensificação do sistema hemostático normal |
US7173000B2 (en) | 2000-11-09 | 2007-02-06 | The Scripps Research Institute | Modified factor VIIa |
US7235638B2 (en) | 2001-03-22 | 2007-06-26 | Novo Nordisk Healthcare A/G | Coagulation factor VII derivatives |
PL371800A1 (en) | 2001-03-22 | 2005-06-27 | Novo Nordisk Health Care Ag | Coagulation factor vii derivatives |
US7052868B2 (en) | 2001-09-27 | 2006-05-30 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
WO2004099231A2 (en) | 2003-04-09 | 2004-11-18 | Neose Technologies, Inc. | Glycopegylation methods and proteins/peptides produced by the methods |
US6858587B2 (en) | 2001-11-02 | 2005-02-22 | Novo Nordisk Pharmaceuticals, Inc. | Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
AU2002336920A1 (en) * | 2001-11-02 | 2003-05-12 | Novo Nordisk Health Care Ag | Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
US6960657B2 (en) | 2001-11-02 | 2005-11-01 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
EP1458408B1 (en) | 2001-12-21 | 2009-04-15 | Novo Nordisk Health Care AG | Liquid composition of factor vii polypeptides |
SI1499719T1 (sl) | 2002-04-30 | 2011-03-31 | Bayer Healthcare Llc | Polipeptidne variante faktorja VII ali VIIa |
EP1517698B2 (en) | 2002-06-21 | 2017-12-06 | Novo Nordisk Health Care AG | STABILISED SOLID COMPOSITIONS OF FACTOR VIIa POLYPEPTIDES |
US6911323B2 (en) | 2002-09-25 | 2005-06-28 | Novo Nordisk Healthcare A/G | Human coagulation factor VII polypeptides |
US20060166874A1 (en) * | 2002-09-30 | 2006-07-27 | Haaning Jesper M | Fvii or fviia variants having increased clotting activity |
WO2004041302A1 (en) * | 2002-11-06 | 2004-05-21 | Novo Nordisk A/S | Pharmaceutical composition comprising a tissue factor antagonist and a blood glucose regulator |
WO2004083361A2 (en) | 2003-03-20 | 2004-09-30 | Maxygen Holdings Ltd. | FVII OR FVIIa VARIANTS |
US7897734B2 (en) | 2003-03-26 | 2011-03-01 | Novo Nordisk Healthcare Ag | Method for the production of proteins |
WO2004103398A1 (en) | 2003-05-23 | 2004-12-02 | Novo Nordisk Health Care Ag | Protein stabilization in solution |
CA2529828C (en) | 2003-06-19 | 2013-01-15 | Maxygen Holdings Ltd. | Factor vii or viia gla domain variants |
JP4658041B2 (ja) | 2003-06-25 | 2011-03-23 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | Vii因子ポリペプチドの液体組成物 |
WO2005012484A2 (en) | 2003-07-25 | 2005-02-10 | Neose Technologies, Inc. | Antibody-toxin conjugates |
EP1656158B1 (en) | 2003-08-14 | 2016-03-09 | Novo Nordisk Health Care AG | Liquid, aqueous pharmaceutical composition of factor vii polypeptides |
CN101870729A (zh) | 2003-09-09 | 2010-10-27 | 诺和诺德医疗保健公司 | 凝固因子ⅶ多肽 |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US20090042784A1 (en) * | 2004-09-29 | 2009-02-12 | Janus Krarup | Purification of a Drug Substance of a Factor VII Polypeptide by Removal of DesGla-Factor VII Polypeptide Structures |
EP1814573B1 (en) | 2004-10-29 | 2016-03-09 | ratiopharm GmbH | Remodeling and glycopegylation of fibroblast growth factor (fgf) |
ES2449195T3 (es) | 2005-01-10 | 2014-03-18 | Ratiopharm Gmbh | Factor estimulante de colonias de granulocitos glicopegilado |
EP1871795A4 (en) | 2005-04-08 | 2010-03-31 | Biogenerix Ag | COMPOSITIONS AND METHOD FOR PRODUCING GLYCOSYLATION MUTANTS OF A PROTEASE-RESISTANT HUMAN GROWTH HORMONE |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
EP1816201A1 (en) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
CN101516388B (zh) | 2006-07-21 | 2012-10-31 | 诺和诺德公司 | 通过o-联糖基化序列的肽的糖基化 |
WO2008057683A2 (en) | 2006-10-03 | 2008-05-15 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates |
KR20100016160A (ko) | 2007-04-03 | 2010-02-12 | 바이오제너릭스 에이지 | 글리코페길화 g―csf를 이용하는 치료 방법 |
WO2008154639A2 (en) | 2007-06-12 | 2008-12-18 | Neose Technologies, Inc. | Improved process for the production of nucleotide sugars |
ES2476690T3 (es) | 2008-02-27 | 2014-07-15 | Novo Nordisk A/S | Moléculas conjugadas del Factor VIII |
ES2856968T3 (es) | 2016-01-15 | 2021-09-28 | Rigshospitalet | Adquisición de imágenes de TEP cuantitativas de la expresión de factor tisular usando factor VII inhibido en el punto activo y marcado con 18F |
MA46864A (fr) | 2016-11-17 | 2021-04-28 | Minerva Imaging Aps | Facteur vii inhibé par le site actif marqué par 177-lu |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0521873B1 (en) * | 1990-01-29 | 1999-06-02 | Zymogenetics, Inc. | Anticoagulant proteins |
JP3459416B2 (ja) * | 1991-02-28 | 2003-10-20 | ザイモジェネティクス,インコーポレイティド | 修飾されたファクター▲vii▼ |
-
1994
- 1994-05-23 JP JP7500869A patent/JPH08510746A/ja not_active Ceased
- 1994-05-23 CA CA002162726A patent/CA2162726A1/en not_active Abandoned
- 1994-05-23 AT AT94918092T patent/ATE210458T1/de not_active IP Right Cessation
- 1994-05-23 WO PCT/US1994/005779 patent/WO1994027631A1/en active IP Right Grant
- 1994-05-23 DK DK94918092T patent/DK0699075T3/da active
- 1994-05-23 EP EP94918092A patent/EP0699075B1/en not_active Expired - Lifetime
- 1994-05-23 PT PT94918092T patent/PT699075E/pt unknown
- 1994-05-23 HU HU9503312A patent/HU219682B/hu not_active IP Right Cessation
- 1994-05-23 DE DE69429429T patent/DE69429429T2/de not_active Expired - Fee Related
- 1994-05-23 AU AU69560/94A patent/AU703110B2/en not_active Ceased
- 1994-05-23 ES ES94918092T patent/ES2169074T3/es not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1994027631A1 (en) | 1994-12-08 |
EP0699075A1 (en) | 1996-03-06 |
ES2169074T3 (es) | 2002-07-01 |
AU703110B2 (en) | 1999-03-18 |
HU219682B (hu) | 2001-06-28 |
DE69429429T2 (de) | 2002-05-16 |
AU6956094A (en) | 1994-12-20 |
HUT73329A (en) | 1996-07-29 |
HU9503312D0 (en) | 1996-01-29 |
DK0699075T3 (da) | 2002-03-11 |
ATE210458T1 (de) | 2001-12-15 |
CA2162726A1 (en) | 1994-12-08 |
DE69429429D1 (de) | 2002-01-24 |
JPH08510746A (ja) | 1996-11-12 |
EP0699075B1 (en) | 2001-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT699075E (pt) | Factor vii modificado para inibicao de restenose vascular e de deposicao de plaquetas | |
MX9702951A (es) | Factor vii modificado. | |
DE69233398D1 (de) | Modifizierter faktor-vii | |
HUP0003077A2 (hu) | Módosított VII faktor | |
TR199801151T2 (xx) | Trombin inhibit�r� �n ila�lar. | |
PT727419E (pt) | Compostos intermediarios para a preparacao de inibidores da protease retroviral | |
ATE177752T1 (de) | Neue inhibitoren von faktor xa | |
ATE175876T1 (de) | Verkürzter gewebsfaktor und fviia oder fvii zur aktivierung der blutgerinnung | |
KR920000785A (ko) | 새로운 혈소판 응집 억제인자 | |
BR9806060A (pt) | Composto, composição farmacêutica e processos para tratar um paciente sofrendo de um estado doentio, para inibir o fator xa, e, para inibir a formação de trombina. | |
FI922609A0 (fi) | Proteiner och nukleinsyror. | |
ATE231837T1 (de) | Hydroxamsäure- und carbonsäurederivate mit mmp und tnf hemmender wirkung | |
BRPI0408477A (pt) | compostos de éster de fosfato/sulfato e composições farmacêuticas para inibir a nima de interação com proteìna (pin 1) e uso dos mesmos | |
NO307687B1 (no) | Anvendelse av riluzol ved fremstilling av medikamenter for behandling av neuro-AIDS | |
CA2060507A1 (en) | Factor xa based anticoagulant compositions | |
EA199900542A1 (ru) | Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида | |
BR0315820A (pt) | Inibidores de integrase de hiv, composições farmacêuticas e métodos para a sua utilização | |
BR9814983A (pt) | Derivado de bifenil-amidina, pró-medicamento; inibidor de coagulação sanguìnea, e, agentes profilático e terapêutico para trombose ou êmbolo. | |
DK0866870T3 (da) | Vævsfaktor-Kunitz-domæne-fusionsproteiner som inhibitorer for faktor Vlla | |
ATE203905T1 (de) | Thrombin inhibitor | |
WO2002074719A3 (en) | Inhibitors of plasmepsins | |
NO943126D0 (no) | 3-alkyloksy-, aryloksy- eller arylalkyloksybenzo-[bÅtiofen-2-karboksamider som hemmere av celleadhesjon | |
BR0209776A (pt) | Composições de inibidores seletivos de ciclo oxigenase-2 e radiação para inibição ou prevenção de doença cardiovascular | |
DE69932434D1 (de) | Prophylaxe und Behandlung von autoimmunen Entmyelinisierungserkrankungen durch Fas-antagonisten | |
FI883730A0 (fi) | Etrar och tioetrar med terapeutisk effekt, framstaellning av dessa och farmaceutiska sammansaettningar som innehaoller dem. |